Novel ApoE peptide derivatives and ApoE-protein transduction domain conjugates are disclosed which are useful for treating disorders including CNS inflammation, traumatic brain injury, inflammatory bowel disease (also known as Crohn's Disease or ulcerative colitis), cerebral ischemia, atherosclerosis, sepsis, multiple sclerosis and arthritic diseases, Alzheimer's Disease and other brain disorders. The invention encompasses methods for protecting subjects having undergone irradiation or radiotherapy by administration of ApoE or at least one ApoE mimetic peptide.
Novel ApoE-protein transduction domain conjugates are disclosed which are useful for treating disorders including CNS inflammation, traumatic brain injury, cerebral ischema, Alzheimer's Disease and other brain disorders.
Eva Garland Consulting, Llc Jan 2016 - Oct 2016
Grant Writing Specialist
Mckenna Consulting Jan 2016 - Oct 2016
Medical Writer
Aje - American Journal Experts Oct 2015 - Nov 2015
Contract Editor
Sfl Regulatory Affairs & Scientific Communication Ltd Mar 1, 2014 - Sep 30, 2014
Medical Communications Manager and Medical Writer
Mckenna Consulting Jan 2010 - Feb 2014
President
Education:
Lehigh University 1992 - 1996
Doctorates, Doctor of Philosophy, Neuroscience
Lehigh University 1989 - 1992
Master of Science, Masters, Psychology
Lehigh University 1987 - 1989
Bachelors, Bachelor of Arts, Psychology
Emory University 1988
Emory University 1984 - 1986
St. Mary's High School
Skills:
Science Clinical Development In Vitro Toxicology Biotechnology Lifesciences In Vivo Dna Drug Development Drug Discovery Editing Medical Writing Research Data Analysis Laboratory Biopharmaceuticals Pharmacology Glp Technical Writing Cro Life Sciences Pharmaceutical Industry